Identification of stage IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.

被引：0
|
作者：
Wever, Renske
Tjien-Fooh, Felicia
Bellomo, Domenico
Quattrocchi, Enrica
Damodaran, Sindhuja Sominidi
Van Vliet, Martin
Dwarkasing, Jvalini
Meves, Alexander
Eggermont, Alexander M.
机构：
[1] SkylineDX BV, Rotterdam, Netherlands
[2] Mayo Clin, Rochester, MN USA
[3] Princess Maxima Ctr, Utrecht, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22088
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model
    Eggermont, Alexander M. M.
    Bellomo, Domenico
    Arias-Mejias, Suzette M.
    Quattrocchi, Enrica
    Sominidi-Damodaran, Sindhuja
    Bridges, Alina G.
    Lehman, Julia S.
    Hieken, Tina J.
    Jakub, James W.
    Murphree, Dennis H.
    Pittelkow, Mark R.
    Sluzevich, Jason C.
    Cappel, Mark A.
    Bagaria, Sanjay P.
    Perniciaro, Charles
    Tjien-Fooh, Felicia J.
    Rentroia-Pacheco, Barbara
    Wever, Renske
    van Vliet, Martin H.
    Dwarkasing, Jvalini
    Meves, Alexander
    EUROPEAN JOURNAL OF CANCER, 2020, 140 : 11 - 18
  • [2] Re: Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model
    Kawada, Tomoyuki
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 516 - 517
  • [3] The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model
    Eggermont, Alexander M. M.
    Bellomo, Domenico
    Dwarkasing, Jvalini
    Meerstein-Kessel, Lisette
    Meves, Alexander
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 518 - 519
  • [4] Using a clinicopathologic and gene expression model to identify melanoma patients at high risk for disease relapse.
    Eggermont, Alexander M.
    Bellomo, Domenico
    Tjien-Fooh, Felicia
    Wever, Renske
    Quattrocchi, Enrica
    Damodaran, Sindhuja Sominidi
    Van Vliet, Martin
    Dwarkasing, Jvalini
    Meves, Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I-II Melanoma Patients at Risk of Disease Relapse
    Mulder, Evalyn E. A. P.
    Johansson, Iva
    Grunhagen, Dirk J.
    Tempel, Dennie
    Rentroia-Pacheco, Barbara
    Dwarkasing, Jvalini T.
    Verver, Danielle
    Mooyaart, Antien L.
    van der Veldt, Astrid A. M.
    Wakkee, Marlies
    Nijsten, Tamar E. C.
    Verhoef, Cornelis
    Mattsson, Jan
    Ny, Lars
    Hollestein, Loes M.
    Bagge, Roger Olofsson
    CANCERS, 2022, 14 (12)
  • [6] Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP)
    Amaral, Teresa
    Sinnberg, Tobias
    Chatziioannou, Eftychia
    Niessner, Heike
    Leiter, Ulrike
    Keim, Ulrike
    Forschner, Andrea
    Dwarkasing, Jvalini
    Tjien-Fooh, Felicia
    Wever, Renske
    Flatz, Lukas
    Eggermont, Alexander
    Forchhammer, Stephan
    EUROPEAN JOURNAL OF CANCER, 2023, 182 : 155 - 162
  • [7] Gene Expression Profiling of Lung Adenocarcinoma Stage I Patients: Risk for Relapse Disease
    Siggillino, A.
    Ludovini, V.
    Bianconi, F.
    Piobbico, D.
    Della Fazia, M. A.
    Tofanetti, F. R.
    Ragusa, M.
    Bellezza, G.
    Servillo, G.
    Crino, L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S124 - S124
  • [8] Primary cutaneous melanoma risk stratification using a clinicopathologic and gene expression model: a pilot study
    Arias-Mejias, Suzette M.
    Quattrocchi, Enrica
    Tempel, Dennie
    Luna-Vargas, Mark
    Chen, Jeff
    Murphree, Dennis H.
    Gjorgova Gjeorgjievski, Sandra
    Lehman, Julia S.
    Bridges, Alina G.
    Dwarkasing, Jvalini
    Meves, Alexander
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (11) : E431 - E433
  • [9] The 31-gene expression profile test for cutaneous melanoma identifies patients with stage IB- IIA disease who have recurrence risk similar to that of stage IIB-IIC disease
    Jarell, Abel
    Morgan-Linnell, Sonia K.
    Martin, Brian
    Bailey, Christine N.
    Goldberg, Matthew S.
    Kurley, Sarah J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB230 - AB230
  • [10] Gene identification for risk of relapse in stage I lung adenocarcinoma patients: a combined methodology of gene expression profiling and computational gene network analysis
    Ludovini, Vienna
    Bianconi, Fortunato
    Siggillino, Annamaria
    Piobbico, Danilo
    Vannucci, Jacopo
    Metro, Giulio
    Chiari, Rita
    Bellezza, Guido
    Puma, Francesco
    Della Fazia, Maria Agnese
    Servillo, Giuseppe
    Crino, Lucio
    ONCOTARGET, 2016, 7 (21) : 30561 - 30574
12345